T cell mediated rejection
Landscape of innate immune system transcriptome and acute T cell–mediated rejection of human kidney allografts
... prevent rejection and drugs are the common means of achieving this, we asked the question whether the drug-induced immunosuppressed state was com- promised in ...clear cell NFAT-regulated gene expression as ...
24
Rationale and design of the RIACT–study: a multi center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial
... acute T-cell mediated rejection of renal allografts, along with intensified maintenance immunosuppressive ther- apy in some cases (KDIGO-Guidelines ...acute T-cell ...
9
Longitudinal immunological characterization of the first presensitized recipient of a face transplant
... antibody-mediated rejection (AMR) following face transplantation have been ...and T cell–mediated rejection (TCMR), there is a critical need to delineate the features that can ...
11
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection
... T cell-mediated rejection (TCMR) is the most com- mon cause of acute rejection [12], and is a major cause of allograft dysfunction and failure ...of rejection as early as ...
9
CD4+ T-cell Mediated Microvascular Endothelial Cell Death and Chronic Cardiac Allograft Rejection Involves Necroptosis
... reduce T-cell activation and proliferation by acting on transcription factors involved with production of IL-2, TNF-α, IFN-γ, IFNβ and granulocyte-macrophage colony stimulating ...of T and ...inhibit ...
92
Mixed chimerism induced without lethal conditioning prevents T cell– and anti Galα1,3Gal–mediated graft rejection
... prevent rejection of vascularized grafts in the combination of a1,3- galactosyltransferase wild-type (GalT +/+ ) and deficient (GalT –/– ) ...both T cells and Gal-reactive B cells, thus preventing ...
11
Treatment of acute antibody-mediated rejection using Rituximab
... Depletion of naive B-cells by rituximab has been reported which is the main reason why rituximab is relatively successful in AMR treatment (7, 14). It is said that this agent does not have any effect on plasma cells; so ...
7
Download Download PDF
... alloreactive T-cells in both GvHD and graft rejection, the capacity for cannabinoids to interrupt antigen presentation and T-cell transformation is highly ...of ...
6
CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30 dependent mechanism
... memory cell apopto- sis (data not shown). The apoptosis of memory T cells was not increased when they were cocultured with Treg cells in transwell that separated Treg and memory cells physically but allowed ...
9
Prevention trumps treatment of antibody mediated transplant rejection
... many T cell–mediated immune responses include a B cell com- ponent, the impact of B cell depletion may extend beyond suppression of measurable antibody (9), as is suggested by the ...
5
Bronchus associated lymphoid tissue–resident Foxp3+ T lymphocytes prevent antibody mediated lung rejection
... Immunosuppression-mediated long-term acceptance of trans- planted lungs is associated with the induction of BALT (Figure 1, A and B, and Supplemental Figure 1A; supplemental mate- rial available online with this ...
14
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection
... by T cells (19, 20, ...chronic rejection (12, 14, 16, 19, ...Th1 cell function and inhibition of macrophage ...on T cell ...acute T cell immune response, may lead to the ...
11
Sirtinol regulates the balance of Th17/Treg to prevent allograft rejection
... They inhibit IL-2 synthesis to prevent the activation and proliferation of T lymphocytes. However, the effect of inhibiting Th17 cells is not achieved because of the dif- ferent activation mechanism of Th17 cells. ...
10
CD4 T cell–mediated cardiac allograft rejection requires donor but not host MHC class II
... CD4 T-cell recognition of donor antigens in the context of recipient MHC class II is not sufficient for acute rejec- ...CD8 T cell–depleted hosts can mount a CD4-dependent indirect response ...
9
Transplant biopsy beyond light microscopy
... on rejection (T cell mediated and antibody-mediated) and the assessment of acute tissue injury, especially in the context of predicting organ function immediately post transplantation ...
7
New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
... Vitiligo induction as a crucial component of melanoma tumor immunotherapy is by no means a new concept. In 1977, Lerner and Nordlund suggested that vitiligo should be induced in patients after resection of primary ...
11
Original Article Acute cellular rejection and antibody-mediated rejection in endomyocardial biopsy after heart transplantation: a retrospective study from a single medical center
... cellular rejection and antibody-mediated rejection after heart transplantation, as detected by ...cellular rejection (ACR) and antibody-mediated rejection (AMR) by histopathology ...
8
MHC ligand generation in T cell-mediated immunity and MHC multimer technologies for T cell detection
... unknown T-cell epitopes from gp100 (QLRALDGGNK), Nodal (SLYRDPLPR and HAYIQSLLK) and Tyrp2 (GTYEGLLRR and ...the T cells with subsequent analysis by conventional MHC multimer staining followed by MHC ...
120
Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
... and T lymphocyte attenuator (BTLA, CD272) is a novel coinhibitory molecule structurally and functionally related to CTLA-4 and ...+ T cells but is progressively downregulated after ...
6
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
... anti-Ly6C antibodies results in a partial depletion of monocytes, decreased infiltration of M1 macrophages in the spinal cord and attenuated neurodegeneration [86], thus indicating a pivotal role of monocytes/macrophages ...
11